The Oncology Institute, Inc. (TOI) — Dilution Risk Analysis

Current Snapshot

The Oncology Institute, Inc. (TOI) has a DilutionWatch score of 65/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
101,916,115 Source
Public Float
87,406,080 Source
Float as % of Outstanding
85.8%

Dilution Risk Score

Score: 65/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 9, 3 1.

FormFiledAccession
4 2026-04-01 0001079973-26-000439
4 2026-04-01 0001079973-26-000440
4 2026-04-01 0001079973-26-000443
4 2026-04-01 0001079973-26-000447
4 2026-04-01 0001079973-26-000449
4 2026-03-30 0000921895-26-000823
4 2026-03-27 0000921895-26-000814
4 2026-03-25 0000921895-26-000796
4 2026-03-23 0001193805-26-000306
3 2026-03-20 0001079973-26-000346

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 0 months Source
Three-year share count growth 38.19% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 65/10) Source
Cash Runway
0 months Source
Share Count Growth (3-Year)
38.19% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.